KB House, Intuitive Surgical and extra

Check out the corporations making headlines after the bell.

Stocks of KB House fell greater than 1.five% in prolonged buying and selling after the corporate reported lighter-than-expected earnings for its fourth quarter. The homebuilder posted $1.31 in profits according to proportion and $1.56 billion in earnings. Analysts anticipated $1.29 in profits according to proportion however $1.61 billion in earnings, in line with Refinitiv. KB House additionally reported extra orders than analysts anticipated, however the moderate sale value dipped rather.

Stocks of Intuitive Surgical rose 2.four% in prolonged buying and selling after liberating initial effects for its fourth quarter. The clinical tool corporate mentioned it expects to file $1.278 billion in earnings for the fourth quarter and $four.479 billion for the entire yr. Each are a minimum of 20% above 2018 effects, in line with the corporate. Intuitive is slated to liberate its ultimate profits file on Jan. 23.

NortonLifeLock‘s inventory rose 2.five% in prolonged buying and selling after the corporate introduced a distinct dividend. The corporate is paying $12 according to proportion, for a complete of kind of $eight billion. NortonLifeLock will file its profits for the fiscal 3rd quarter subsequent month.

Portola Pharmaceutical noticed its inventory drop 39% in prolonged buying and selling after liberating initial earnings numbers. The corporate mentioned that internet earnings from its Andexxa drug in the US was once kind of $24 million for the fourth quarter. This was once greater than the fourth quarter the yr prior, however a $nine million lower from its leads to the 3rd quarter. The corporate mentioned declining call for because of adjustments in health center usage was once one explanation why for shrinking earnings.

Stocks of Moderna spiked greater than 15% after hours following the discharge of knowledge that display certain protection effects for a vaccine the corporate is growing. Moderna has already begun segment two of trying out for the vaccine, which is meant to forestall cytomegalovirus. The corporate mentioned segment 3 of trying out may just start subsequent yr.